Cargando…
Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
Glioblastoma (GBM) is the most common malignant brain tumor. Although current treatment strategies, including surgery, chemotherapy, and radiotherapy, have achieved clinical effects and prolonged the survival of patients, the gradual development of resistance against current therapies has led to a h...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Compuscript
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246442/ https://www.ncbi.nlm.nih.gov/pubmed/37144620 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0761 |